NCT02549937 2024-07-10A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid TumorsHutchmedPhase 1/2 Completed130 enrolled 30 charts
NCT02177773 2019-11-12DOTA-TOCUniversity of California, San FranciscoPhase 1/2 Terminated300 enrolled 5 charts